Trends in antimalarial prescriptions in Australia from 1998 to 2002

Journal of Travel Medicine

Volumn 12, Issue 6, 2005, Pages 338-342

  Leggat, Peter A ^a  

^a JAMES COOK UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; DOXYCYCLINE; FOLIC ACID ANTAGONIST; MALOPRIM; MEFLOQUINE; NEW DRUG; PROGUANIL; PYRIMETHAMINE; SULFADOXINE;

ARTICLE; AUSTRALIA; CHEMOPROPHYLAXIS; CONTINUING EDUCATION; DRUG UTILIZATION; HUMAN; INFECTION PREVENTION; MALARIA; MULTIDRUG RESISTANCE; PLASMODIUM FALCIPARUM; PRACTICE GUIDELINE; PRESCRIPTION; TRAVEL;

EID: 30944444348     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.2310/7060.2005.12607     Document Type: Article

References (27)

1. World Health Organization. Malaria. Fact sheet no. 94. Available at: http://www.who.int/mediacentre/factsheets/fs094/en/print.html. (Accessed 2005 Feb 8)
2. Australian Bureau of Statistics. 9.25 National Notifiable Disease Surveillance System reports-1998 to 2000. Year Book Australia 2002. Catalogue No. 1301.0. Canberra: Australian Government Publishing Service, 2002.
3. Australian Bureau of Statistics. 9.27 National Notifiable Disease Surveillance System 2eports. Year Book Australia. Catalogue No. 1301.0. Canberra: Australian Government Publishing Service, 2005.
4. Harvey B. Trends in malaria in Australia, 1991-1997. Commun Dis Intell 1998; 22:247-248.
5. Charles DM, Hart J, Davis WA, et al. Notifications of imported malaria in Western Australia, 1990-2001: incidence, associated factors and chemoprophylaxis. Med J Aust 2005; 182:164-167.
6. Lewis SJ, Davidson RN, Ross EJ, Hall AP. Severity of imported malaria: effect of taking antimalarial prophylaxis. BMJ 1992; 305:741-3.
7. Davis TM, Breheny FX, Kendal PA, et al. Severe falciparum malaria with hyperparasitaemia treated with intravenous artesunate. Med J Aust 1997; 166:416-418.
8. Robinson P, Jenney AW, Tachado M, et al. Imported malaria treated in Melbourne, Australia: epidemiology and clinical features in 246 patients. J Travel Med 2000; 8:76-81.
9. Commonwealth Department of Health. Health information for international travel, 1995. 4th Ed. Canberra: Australian Government Publishing Service, 1994.
10. Harvey K. Therapeutic guidelines: antibiotic. 10th Ed. North Melbourne: Therapeutic Guidelines Limited, 1998.
11. Spicer J. Therapeutic guidelines: antibiotic. Version 11. North Melbourne: Therapeutic Guidelines Limited, 2000.
12. McCall BJ, Pearce MC. Malaria treatment in Queensland, 1992. The use of malaria treatment guidelines. Med J Aust 1994; 161:259-262.
13. Leggat PA, Speare R. Trends in antimalarial drugs prescribed in Australia, 1992-1998. J Travel Med 2003; 10:189-191.
14. Australian Bureau of Statistics. 21.14 Australians travelling abroad. Year Book Australia. Catalogue No. 1301.0. Canberra: Australian Government Publishing Service, 2004.
15. Pharmaceutical Benefits Advisory Committee, Drug Utilization Sub-Committee. Australian statistics on medicines 1998. Canberra: Australian Government Publishing Service, 2000.
16. Pharmaceutical Benefits Advisory Committee, Drug Utilization Sub-Committee. Australian Statistics on Medicines 1999-2000. Canberra: Australian Government Publishing Service, 2003.
17. Pharmaceutical Benefits Advisory Committee, Drug Utilization Sub-Committee. Australian Statistics on Medicines 2001-2002. Canberra: Australian Government Publishing Service, 2004.
18. Williams A, Lewis DJM. Malaria prophylaxis: a postal questionnaire survey of general practitioners in South Wales. BMJ 1987; 295:1449-1452.
19. Leggat PA, Heydon JL. Trends in antimalarial drugs prescribed in New Zealand 1993-1998. J Travel Med 2002; 9:156-159.
20. Leggat PA, Dürrheim DN, Blumberg L. Trends in malaria chemoprophylaxis prescription in South Africa 1994-2000. J Travel Med 2002; 9:318-321.
21. Coole L, Wiselka MJ, Nicholson KG. Malaria prophylaxis in travellers from Britain. J Infect 1989; 18:209-212.
22. Phillips-Howard PA, West LJ. Severe adverse reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and amodiaquine in Britain. J R Soc Med 1990; 83:82-85.
23. Athan E, Durrheim DN, Barnes K, et al. Effectiveness of short-course quinine and single-dose sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria in Mpumalanga Province, South Africa. S Afr Med J 2001; 91:592-594.
24. Kain KC. Prophylactic drugs for malaria: why do we need another one? J Travel Med 1999; 6(Suppl 1):S2-S7.
25. Edstein MD, Nasveld PE, Rieckmann KH. The challenge of effective chemoprophylaxis against malaria. Aust Def Force Health 2001; 2:12-16.
26. Dürrheim DN, Leggat PA, Shanks GD. Malaria prevention. In: Leggat PA, Goldsmid JM, eds. Primer of travel medicine. 3rd Ed. Brisbane: ACTM Publications, 2002:38-54.
27. Spicer J. Therapeutic guidelines: antibiotic. Version 12. North Melbourne: Therapeutic Guidelines Limited, 2003.